BY Midnight Trader — 4:31 PM ET 06/02/2016
http://stockcharts.com/h-sc/ui?s=COO
Cooper (COO) advanced in extended trading after the medical device company reported higher-than-expected profit and revenue in its fiscal second quarter.
Shares of the Pleasanton, California-based company gained as much as 1.6% after adding 1% to $167.32 at the close of regular trading on Thursday. The stock is up 25% so far this year.
GAAP net income attributable to Cooper stockholders rose to $74.1 million, or $1.52 per share, for the three months ended April 30, from $60.7 million, or $0.29 per diluted share, for the year-earlier period.
Non-GAAP EPS was $2.05, surpassing the $1.92 average estimate of 14 analysts polled by Capital IQ.
Q2 revenue increased 11% year-over-year to $483.8 million, topping the Wall Street consensus of $464 million.
Looking ahead, the company anticipates non-GAAP EPS for the full year to be in the range of $8.20 and $8.50 per share on revenue in the range of $1.92 billion and $1.96 billion. Analysts are looking for EPS of $8.29 on revenue of $1.90 billion.
Price: 173.55, Change: +6.13, Percent Change: +3.66
Recent COO News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2024 08:57:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/18/2024 09:05:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/09/2024 04:42:12 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/04/2024 05:40:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2024 10:03:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2024 10:03:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2024 09:53:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2024 09:53:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2024 09:53:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2024 09:52:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2024 09:52:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2024 08:22:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2024 10:58:08 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/18/2024 08:18:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/14/2024 11:53:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:01:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:00:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 11:05:54 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 10:04:43 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 04:38:07 PM
- Cooper Companies Inc Elevates Annual Revenue Forecast Following Strong Quarterly Sales • IH Market News • 03/01/2024 11:40:32 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:20:28 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/02/2024 10:16:44 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/02/2024 10:16:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 12:15:33 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM